Working title: Morning and nocturnal symptomatology in patients with suspected deventilation syndrome.

Working title: Morning and nocturnal symptomatology in patients with suspected deventilation syndrome. - DEVENT-2

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027955

Enrollment

Registered

2022-02-03

Start date

2022-02-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J44.9 J96.9

Interventions

Group 1: Single arm study Measurements: 1. symptom documentation related to pulmonary functional, respiratory muscular and polysomnographic parameters. 2. identification of ventilator settings relat

Eligibility

Sex/Gender

All

Age

18 Years to 120 Years

Inclusion criteria

Inclusion criteria: - Patients with pre-existing COPD of any stage according to GOLD with established NIV therapy and symptoms of deventilation syndrome. - informed consent - Cognitive and verbal ability to respond to the questionnaires

Exclusion criteria

Exclusion criteria: - Patient age <18 years - Deafness, Alexia - Not able to give consent

Design outcomes

Primary

Measure	Time frame
Pulmonary function change immediately following nocturnal NIV therapy in patients with suspected deventilation syndrome.	—

Secondary

Measure	Time frame
1. symptom documentation related to pulmonary functional, respiratory muscular and polysomnographic parameters. 2. identification of ventilator settings for therapy of DVS.	—

Countries

Germany

Contacts

Public ContactMaximilian Wollsching-Strobel

Kliniken der Stadt Köln gGmbH, Lungenklinik Standort-Merheim, Universität Witten/Herdecke

wollschingstrobelm@kliniken-koeln.de+ 49 221 8907 - 18929

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026